Rankings
▼
Calendar
SION Q4 2024 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SION
Sionna Therapeutics, Inc.
$2B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$16M
EPS (Diluted)
$-0.36
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$186M
Total Liabilities
$349M
Stockholders' Equity
-$164M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$18M
-$13M
-44.0%
Net Income
-$16M
-$12M
-33.4%
← FY 2024
All Quarters
Q1 2025 →